Jean-Nicolas Tournier

Prof. Jean-Nicolas Tournier


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2022 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
GFGaëlle Frenois-Veyrat
Gaëlle Frenois-Veyrat
FGFranck Gallardo
Franck Gallardo
OGOlivier Gorgé
Olivier Gorgé
EMElie Marcheteau
Elie Marcheteau
OFOlivier Ferraris
Olivier Ferraris
JTJean-Nicolas Tournier
Jean-Nicolas Tournier

1 February 2014 in Infection and Immunity
Verified
Journal Article
Open access
PDF file
DFDaniel Fiole
Daniel Fiole
PDPierre Deman
Pierre Deman
YTYannick Trescos
Yannick Trescos
JMJean-François Mayol
Jean-François Mayol
JMJacques Mathieu
Jacques Mathieu
JTJean-Nicolas Tournier
Jean-Nicolas Tournier
The dynamics of the lung immune system at the microscopic level are largely unknown because of inefficient methods of restraining chest motion during image acquisition. In this study, we developed an improved intravital method for two-photon lung imaging uniquely based on a posteriori parenchymal tissue motion correction. We took advantage of the alveolar collagen pattern given by the second harmonic generation signal as a reference for frame registration. We describe here for the first time a detailed dynamic account of two major lung immune cell populations, alveolar macrophages and CD11b-positive dendritic cells, during homeostasis and infection by spores of Bacillus anthracis , the agent of anthrax. We show that after alveolar macrophages capture spores, CD11b-positive dendritic cells come in prolonged contact with infected macrophages. Dendritic cells are known to carry spores to the draining lymph nodes and elicit the immune response in pulmonary anthrax. The intimate and long-lasting contacts between these two lines of defense may therefore coordinate immune responses in the lung through an immunological synapse-like process.

1 January 2012 in Infection and Immunity
Verified
Journal Article
Open access
PDF file
KGKévin Garraud
Kévin Garraud
ACAurélie Cleret
Aurélie Cleret
JMJacques Mathieu
Jacques Mathieu
DFDaniel Fiole
Daniel Fiole
YGYves Gauthier
Yves Gauthier
JTJean-Nicolas Tournier
Jean-Nicolas Tournier
The roles of interleukin-17 (IL-17) and neutrophils in the lung have been described as those of two intricate but independent players. Here we identify neutrophils as the primary IL-17-secreting subset of cells in a model of inhalation anthrax using A/J and C57BL/6 mice. With IL-17 receptor A knockout (IL-17RA −/− ) mice, we confirmed that IL-17A/F signaling is instrumental in the self-recruitment of this population. We also show that the IL-17A/F axis is critical for surviving pulmonary infection, as IL-17RA −/− mice become susceptible to intranasal infection by Bacillus anthracis Sterne spores. Strikingly, infection with a fully virulent strain did not affect IL-17RA −/− mouse survival. Eventually, by depleting neutrophils in wild-type and IL-17RA −/− mice, we demonstrated the crucial role of IL-17-secreting neutrophils in mouse survival of infection by fully virulent B. anthracis . This work demonstrates the important roles of both IL-17 signaling and neutrophils in clearing this pathogen and surviving pulmonary B. anthracis infection.

1 November 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
PFPhanramphoei N. Frantz
Phanramphoei N. Frantz
ABAleksandr Barinov
Aleksandr Barinov
CRClaude Ruffié
Claude Ruffié
CCChantal Combredet
Chantal Combredet
VNValérie Najburg
Valérie Najburg
FTFrédéric Tangy
Frédéric Tangy
Several COVID-19 vaccines have now been deployed to tackle the SARS-CoV-2 pandemic, most of them based on messenger RNA or adenovirus vectors.The duration of protection afforded by these vaccines is unknown, as well as their capacity to protect from emerging new variants. To provide sufficient coverage for the world population, additional strategies need to be tested. The live pediatric measles vaccine (MV) is an attractive approach, given its extensive safety and efficacy history, along with its established large-scale manufacturing capacity. We develop an MV-based SARS-CoV-2 vaccine expressing the prefusion-stabilized, membrane-anchored full-length S antigen, which proves to be efficient at eliciting strong Th1-dominant T-cell responses and high neutralizing antibody titers. In both mouse and golden Syrian hamster models, these responses protect the animals from intranasal infectious challenge. Additionally, the elicited antibodies efficiently neutralize in vitro the three currently circulating variants of SARS-CoV-2.

29 January 2021 in Toxins
Verified
Journal Article
Open access
PDF file
MDMaria Lucia Orsini Delgado
Maria Lucia Orsini Delgado
AAArnaud AVRIL
Arnaud AVRIL
JPJulie Prigent
Julie Prigent
JDJulie Dano
Julie Dano
ARAudrey Rouaix
Audrey Rouaix
SSStéphanie Simon
Stéphanie Simon
Ricin, a highly toxic protein from Ricinus communis, is considered a potential biowarfare agent. Despite the many data available, no specific treatment has yet been approved. Due to their ability to provide immediate protection, antibodies (Abs) are an approach of choice. However, their high specificity might compromise their capacity to protect against the different ricin isoforms (D and E) found in the different cultivars. In previous work, we have shown the neutralizing potential of different Abs (43RCA-G1 (anti ricin A-chain) and RB34 and RB37 (anti ricin B-chain)) against ricin D. In this study, we evaluated their protective capacity against both ricin isoforms. We show that: (i) RB34 and RB37 recognize exclusively ricin D, whereas 43RCA-G1 recognizes both isoforms, (ii) their neutralizing capacity in vitro varies depending on the cultivar, and (iii) there is a synergistic effect when combining RB34 and 43RCA-G1. This effect is also demonstrated in vivo in a mouse model of intranasal intoxication with ricin D/E (1:1), where approximately 60% and 40% of mice treated 0 and 6 h after intoxication, respectively, are protected. Our results highlight the importance of evaluating the effectiveness of the Abs against different ricin isoforms to identify the treatment with the broadest spectrum neutralizing effect.

1 August 2015 in Infection and Immunity
Verified
Journal Article
Open access
PDF file
YTYannick Trescos
Yannick Trescos
ETEmilie Tessier
Emilie Tessier
CRClémence Rougeaux
Clémence Rougeaux
PGPierre L. Goossens
Pierre L. Goossens
JTJean-Nicolas Tournier
Jean-Nicolas Tournier
Bacillus anthracis secretes the edema toxin (ET) that disrupts the cellular physiology of endothelial and immune cells, ultimately affecting the adherens junction integrity of blood vessels that in turn leads to edema. The effects of ET on the cytoskeleton, which is critical in cell physiology, have not been described thus far on macrophages. In this study, we have developed different adhesive micropatterned surfaces (L and crossbow) to control the shape of bone marrow-derived macrophages (BMDMs) and primary peritoneal macrophages. We found that macrophage F-actin cytoskeleton adopts a specific polar organization slightly different from classical human HeLa cells on the micropatterns. Moreover, ET induced a major quantitative reorganization of F-actin within 16 h with a collapse at the non-adhesive side of BMDMs along the nucleus. There was an increase in size and deformation into a kidney-like shape, followed by a decrease in size that correlates with a global cellular collapse. The collapse of F actin was correlated with a release of focal adhesion on the patterns and decreased cell size. Finally, the cell nucleus was affected by actin reorganization. By using this technology we could describe many previously unknown macrophage cellular dysfunctions induced by ET. This novel tool could be used to analyse more broadly the effects of toxins and other virulence factors that target the cytoskeleton.